Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection

Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection

Background and Aims This study aimed to clarify the clinical picture of hepatitis C virus (HCV) carriers with normal alanine aminotransferase (CNALT) and those with ALT elevation (non‐CNALT) under direct‐acting antivirals (DAAs). Methods We enrolled 1002 patients with HCV (427 men, median age: 69 ye...

Full description

Bibliographic Details
Main Authors: Satoru Joshita, Ayumi Sugiura, Takeji Umemura, Tomoo Yamazaki, Naoyuki Fujimori, Akihiro Matsumoto, Yoko Usami, Eiji Tanaka
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:JGH Open
Subjects:
direct‐acting antiviral
hepatitis C virus carrier with normal alanine aminotransferase
hepatitis C virus
hepatocellular carcinoma
Online Access:https://doi.org/10.1002/jgh3.12296

Similar Items

Similar Items